S 1784
MAPS Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 7:59 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Mapping America’s Pharmaceutical Supply Act (MAPS Act) aims to strengthen the U.S. pharmaceutical supply chain by improving coordination among federal agencies. It establishes a list of essential medicines, conducts risk assessments of those supply chains, and maps the supply chains themselves using data analytics to identify vulnerabilities. The bill also requires regular reporting on these efforts to Congress and the intelligence community, with a focus on national security risks.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Angus S., Jr. King
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.